These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2098412)

  • 1. Field evaluation of measles vaccine efficacy in New Seemapuri, Shahdara Zone-Delhi during 1990.
    Chawla U; Benera SK; Bandyopadhyay S; Chaudhary BN; Gupta OP; Khallendra RK; Ramaswamy J; Khare S; Sharma RS; Dutta KK
    J Commun Dis; 1990 Jun; 22(2):134-9. PubMed ID: 2098412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with a measles vaccine manufactured in India.
    Shaikh N; Raut SK; Bedekar SS; Phadke MA; Banerjee K
    Indian Pediatr; 1992 Jul; 29(7):883-7. PubMed ID: 1428138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of three measles vaccines in Indian children.
    Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
    Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field evaluation of measles vaccine efficacy in Najafgarh zone of delhi.
    Sharma RS; Chawla U; Datta KK
    J Commun Dis; 1988 Mar; 20(1):38-43. PubMed ID: 3230287
    [No Abstract]   [Full Text] [Related]  

  • 6. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria.
    Omilabu SA; Oyefolu AO; Ojo OO; Audu RA
    Afr J Med Med Sci; 1999; 28(3-4):209-12. PubMed ID: 11205835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G; Boulianne N; Ratnam S; Corriveau A
    Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles, immunisation and disease: rapid epidemiological assessment in two trans-Yamuna villages of Delhi.
    Chaturvedi S; Aggarwal OP
    J Indian Med Assoc; 2000 Jul; 98(7):381-3. PubMed ID: 11143858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI; Moyo IM; Mbengeranwa LO
    Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy evaluation of measles vaccine in fields].
    Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):292-4. PubMed ID: 1782660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles and measles vaccine efficacy in a remote island population.
    McIntyre RC; Preblud SR; Polloi A; Korean M
    Bull World Health Organ; 1982; 60(5):767-75. PubMed ID: 6983927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 14. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P; Branciaroli A; Di Battista S; Di Filippo A; Di Pietro M; Calafiore P; Di Battista C
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity against measles among vaccinated school going children in Zahedan, southeast of Iran.
    Mood BS; Naini RN; Salehi M; Kouhpayeh HR; Azad TM; Poor TN
    Indian J Med Microbiol; 2005 Oct; 23(4):274-5. PubMed ID: 16327132
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003.
    Tischer A; Santibanez S; Siedler A; Heider A; Hengel H
    J Clin Virol; 2004 Nov; 31(3):165-78. PubMed ID: 15465408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G; Petersen I; Mordhorst CH
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field trial of a heat-stable measles vaccine in Papua New Guinea.
    Climie A; André FE
    J Trop Med Hyg; 1984 Dec; 87(6):249-55. PubMed ID: 6534989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.